BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21207090)

  • 21. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.
    Bouma W; Klinkenberg TJ; van der Horst IC; Wijdh-den Hamer IJ; Erasmus ME; Bijl M; Suurmeijer AJ; Zijlstra F; Mariani MA
    J Cardiothorac Surg; 2010 Mar; 5():13. PubMed ID: 20331896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies].
    Lolli C; Foscoli M; Giofrè R; Tarquinii M; Pasquali S; Toschi GP
    G Ital Cardiol; 1993 Nov; 23(11):1125-34. PubMed ID: 8163102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus.
    Gleason CB; Stoddard MF; Wagner SG; Longaker RA; Pierangeli S; Harris EN
    Am Heart J; 1993 Apr; 125(4):1123-9. PubMed ID: 8465738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases.
    Chalvon NB; Costedoat-Chalumeau N; Pennaforte JL; Servettaz A; Boulagnon Rombi C; Gavand PE; Lekieffre M; Le Guern V; Morel N; Cohen Aubart F; Haroche J; Mathian A; Collet JP; Piette JC; Amoura Z; Orquevaux P
    Rheumatology (Oxford); 2023 Feb; 62(2):707-715. PubMed ID: 35686908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Libman-Sacks endocarditis and embolic cerebrovascular disease.
    Roldan CA; Sibbitt WL; Qualls CR; Jung RE; Greene ER; Gasparovic CM; Hayek RA; Charlton GA; Crookston K
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):973-83. PubMed ID: 24029368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Tale of Two Valves: Bioprosthetic Aortic Valve Obstruction in Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.
    Dietrich M; Bois M; Ferrufino R; Cobey F; Mankad R
    J Cardiothorac Vasc Anesth; 2020 Dec; 34(12):3462-3466. PubMed ID: 32800619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Bernardoff I; Picq A; Loiseau P; Foret T; Dufrost V; Moulinet T; Unlu O; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2022 Jan; 21(1):102913. PubMed ID: 34371159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral embolism from Libman-Sacks endocarditis.
    Malvar B; Almeida FM; Rebocho L; Moniz JC; Azevedo F
    BMJ Case Rep; 2011 Jun; 2011():. PubMed ID: 22693297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive disorders and antiphospholipid antibodies.
    Yelnik CM; Kozora E; Appenzeller S
    Autoimmun Rev; 2016 Dec; 15(12):1193-1198. PubMed ID: 27639839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiographic features in antiphospholipid-negative Sneddon's syndrome and potential association with severity of neurological symptoms or recurrence of strokes: a longitudinal cohort study.
    Assan F; de Zuttere D; Bottin L; Tavolaro S; Courvoisier DS; Barbaud A; Alamowitch S; Francès C; Chasset F
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):119-128. PubMed ID: 31898726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Meta-analysis and Systematic Review of Valvular Heart Disease in Systemic Lupus Erythematosus and Its Association With Antiphospholipid Antibodies.
    Hussain K; Gauto-Mariotti E; Cattoni HM; Arif AW; Richardson C; Manadan A; Yadav N
    J Clin Rheumatol; 2021 Dec; 27(8):e525-e532. PubMed ID: 32558678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Libman-Sacks Endocarditis: Detection, Characterization, and Clinical Correlates by Three-Dimensional Transesophageal Echocardiography.
    Roldan CA; Tolstrup K; Macias L; Qualls CR; Maynard D; Charlton G; Sibbitt WL
    J Am Soc Echocardiogr; 2015 Jul; 28(7):770-9. PubMed ID: 25807885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination of Libman-Sacks endocarditis with infectious endocarditis].
    Demin AA; Sentiakova TN
    Klin Med (Mosk); 2002; 80(3):28-33. PubMed ID: 11980154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupus-Negative Libman-Sacks Endocarditis Complicated by Catastrophic Antiphospholipid Syndrome.
    Murtaza G; Iskandar J; Humphrey T; Adhikari S; Kuruvilla A
    Cardiol Res; 2017 Apr; 8(2):57-62. PubMed ID: 28515823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrent multi-focal cerebral stroke complicating Libman-Sacks endocarditis in a young woman with systemic lupus erythromatosus].
    Jedliński I; Duszyńska M; Lehmann-Kopydłowska A; Jamrozek-Jedlińska M; Poprawski K; Zawilska K
    Kardiol Pol; 2009 Jan; 67(1):50-2. PubMed ID: 19253190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
    Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
    Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.